GlassScriptPhysician profile
Srikanth Vallurupalli
NPI 1104919182
$5,318.43
in general payments reported to CMS, 2019-2025
12 companies · $2,226 in 2025
The $2,226 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $105 · 2023: $1,578 · 2024: $160 · 2025: $2,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,398 · Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,397.61 |
| Food and Beverage | $1,566.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,876.00 | 2024-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,696.64 | 2020-2024 | Watchman Access System |
| Abbott Laboratories | $1,337.07 | 2019-2024 | Mitraclip |
| Heartflow, INC. | $168.48 | 2025 | |
| Impulse Dynamics (USA) INC. | $133.84 | 2025 | Optimizer |
| Abiomed | $27.71 | 2025 | |
| Janssen Pharmaceuticals, INC | $23.85 | 2019 | |
| Pfizer INC. | $21.23 | 2025 | |
| Cardiva Medical, INC. | $18.14 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lantheus Medical Imaging, INC. | $15.47 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Vallurupalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.